143 related articles for article (PubMed ID: 23337713)
1. The clinical impact of uncertainties in the mean excitation energy of human tissues during proton therapy.
Besemer A; Paganetti H; Bednarz B
Phys Med Biol; 2013 Feb; 58(4):887-902. PubMed ID: 23337713
[TBL] [Abstract][Full Text] [Related]
2. Optimized I-values for use with the Bragg additivity rule and their impact on proton stopping power and range uncertainty.
Bär E; Andreo P; Lalonde A; Royle G; Bouchard H
Phys Med Biol; 2018 Aug; 63(16):165007. PubMed ID: 29999493
[TBL] [Abstract][Full Text] [Related]
3. Statistical assessment of proton treatment plans under setup and range uncertainties.
Park PC; Cheung JP; Zhu XR; Lee AK; Sahoo N; Tucker SL; Liu W; Li H; Mohan R; Court LE; Dong L
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):1007-13. PubMed ID: 23688812
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
5. A spot-specific range uncertainty framework for robust optimization of proton therapy treatments.
Cohilis M; Souris K; Buti G; Chang CW; Lin L; Lee JA; Sterpin E
Med Phys; 2023 Oct; 50(10):6554-6568. PubMed ID: 37676906
[TBL] [Abstract][Full Text] [Related]
6. Acoustic-based proton range verification in heterogeneous tissue: simulation studies.
Jones KC; Nie W; Chu JCH; Turian JV; Kassaee A; Sehgal CM; Avery S
Phys Med Biol; 2018 Jan; 63(2):025018. PubMed ID: 29176057
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
8. Effects of Hounsfield number conversion on CT based proton Monte Carlo dose calculations.
Jiang H; Seco J; Paganetti H
Med Phys; 2007 Apr; 34(4):1439-49. PubMed ID: 17500475
[TBL] [Abstract][Full Text] [Related]
9. Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy.
Frey K; Unholtz D; Bauer J; Debus J; Min CH; Bortfeld T; Paganetti H; Parodi K
Phys Med Biol; 2014 Oct; 59(19):5903-19. PubMed ID: 25211629
[TBL] [Abstract][Full Text] [Related]
10. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
11. Efficient uncertainty quantification for Monte Carlo dose calculations using importance (re-)weighting.
Stammer P; Burigo L; Jäkel O; Frank M; Wahl N
Phys Med Biol; 2021 Oct; 66(20):. PubMed ID: 34544068
[No Abstract] [Full Text] [Related]
12. Uncertainty incorporated beam angle optimization for IMPT treatment planning.
Cao W; Lim GJ; Lee A; Li Y; Liu W; Ronald Zhu X; Zhang X
Med Phys; 2012 Aug; 39(8):5248-56. PubMed ID: 22894449
[TBL] [Abstract][Full Text] [Related]
13. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
[TBL] [Abstract][Full Text] [Related]
14. The influence of patient positioning uncertainties in proton radiotherapy on proton range and dose distributions.
Liebl J; Paganetti H; Zhu M; Winey BA
Med Phys; 2014 Sep; 41(9):091711. PubMed ID: 25186386
[TBL] [Abstract][Full Text] [Related]
15. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
Bai X; Lim G; Grosshans D; Mohan R; Cao W
Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
[TBL] [Abstract][Full Text] [Related]
16. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
17. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
[TBL] [Abstract][Full Text] [Related]
18. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
19. Toward a new treatment planning approach accounting for in vivo proton range verification.
Tian L; Landry G; Dedes G; Kamp F; Pinto M; Niepel K; Belka C; Parodi K
Phys Med Biol; 2018 Oct; 63(21):215025. PubMed ID: 30375361
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo proton dose calculations using a radiotherapy specific dual-energy CT scanner for tissue segmentation and range assessment.
Almeida IP; Schyns LEJR; Vaniqui A; van der Heyden B; Dedes G; Resch AF; Kamp F; Zindler JD; Parodi K; Landry G; Verhaegen F
Phys Med Biol; 2018 May; 63(11):115008. PubMed ID: 29616662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
